8-K - PRECISION BIOSCIENCES INC (0001357874) (Filer)
Published . Updated .
Key takeaways
- 8-K - PRECISION BIOSCIENCES filed an 8-K with the SEC on Nov 9 (a notice of a material company event).
- Exposed: DTIL
- Market reaction: DTIL −13.9% after two sessions
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - PRECISION BIOSCIENCES filed an 8-K with the SEC on Nov 9 (a notice of a material company event).
Directly affected
- DTIL Precision Biosciences+52.6% 13d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Precision BioSciences belongs to, so it often moves with news about it.
- AMGN Amgen+10.3% 30d
Amgen is a peer of Precision BioSciences in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+18.5% 30d
Gilead Sciences is a peer of Precision BioSciences in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+23.2% 30d
Moderna is a peer of Precision BioSciences in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-11.9% 9d
argenx SE is a peer of Precision BioSciences in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Precision BioSciences in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| DTIL | -34.34% | -23.87% | base | -8.96% | -10.09% | -13.87% | after close |
| XLV | -0.10% | +2.63% | base | +1.94% | +2.20% | +2.22% | after close |
| AMGN | +1.13% | +3.87% | base | +1.07% | +1.04% | +1.71% | after close |
| GILD | +2.11% | +4.54% | base | +1.50% | +2.39% | +1.69% | after close |
| MRNA | -13.21% | +1.53% | base | +5.70% | -1.50% | -2.28% | after close |
| ARGX | -5.82% | +0.29% | base | +3.72% | +4.72% | +5.27% | after close |
| RVMD | -2.15% | +3.75% | base | +4.13% | +0.43% | -6.06% | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-09 AccNo: 0001628280-26-071867 Size: 147 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Precision Biosciences (DTIL)
Those 3 earlier stories put Precision Biosciences (DTIL) at an average move of +15.09% the next day. Largest gain +31.35%, largest drop -2.03%, from 3 prices.
| Company | When | Average | Largest gain | Largest drop | Prices |
|---|---|---|---|---|---|
| Precision Biosciences (DTIL) | the next day | +15.09% | +31.35% | -2.03% | 3 |
| Precision Biosciences (DTIL) | three days later | +21.03% | +52.30% | -7.31% | 3 |
The price since 9 Nov 2026: Precision Biosciences (DTIL) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| AMGN | that day | +1.07% | final price |
| AMGN | the next day | +1.04% | final price |
| AMGN | two days later | +1.71% | final price |
| AMGN | three days earlier | +3.87% | final price |
| AMGN | five days earlier | +1.13% | final price |
| ARGX | that day | +3.72% | final price |
| ARGX | the next day | +4.72% | final price |
| ARGX | two days later | +5.27% | final price |
| ARGX | three days earlier | +0.29% | final price |
| ARGX | five days earlier | -5.82% | final price |
| Precision Biosciences (DTIL) | that day | -8.96% | final price |
| Precision Biosciences (DTIL) | the next day | -10.09% | final price |
| Precision Biosciences (DTIL) | two days later | -13.87% | final price |
| Precision Biosciences (DTIL) | three days earlier | -23.87% | final price |
| Precision Biosciences (DTIL) | five days earlier | -34.34% | final price |
| GILD | that day | +1.50% | final price |
| GILD | the next day | +2.39% | final price |
| GILD | two days later | +1.69% | final price |
| GILD | three days earlier | +4.54% | final price |
| GILD | five days earlier | +2.11% | final price |
| MRNA | that day | +5.70% | final price |
| MRNA | the next day | -1.50% | final price |
| MRNA | two days later | -2.28% | final price |
| MRNA | three days earlier | +1.53% | final price |
| MRNA | five days earlier | -13.21% | final price |
| RVMD | that day | +4.13% | final price |
| RVMD | the next day | +0.43% | final price |
| RVMD | two days later | -6.06% | final price |
| RVMD | three days earlier | +3.75% | final price |
| RVMD | five days earlier | -2.15% | final price |
| XLV | that day | +1.94% | final price |
| XLV | the next day | +2.20% | final price |
| XLV | two days later | +2.22% | final price |
| XLV | three days earlier | +2.63% | final price |
| XLV | five days earlier | -0.10% | final price |
Trades by members of Congress and officials in the stocks in this story
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $15,001 - $50,000 on 15 Oct 2026. That is 25 days before publication. Filed 2 Nov 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 48 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 75 days before publication. Filed 5 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 46 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 66 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 73 days before publication. Filed 8 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Precision Biosciences (DTIL)
Companies tied to this story
- DTIL Precision Biosciences
For “8-K - PRECISION BIOSCIENCES INC (0001357874) (Filer),” Precision Biosciences (DTIL) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> DTIL
How “8-K - PRECISION BIOSCIENCES INC (0001357874) (Filer)” reaches Precision Biosciences (DTIL)
On 9 Nov 2026, “8-K - PRECISION BIOSCIENCES INC (0001357874) (Filer)” is the story that connects Precision Biosciences (DTIL) to this story.
Precision Biosciences (DTIL) is on the page because SEC 8-K filing -> direct issuer disclosure -> DTIL
Price levels for Precision Biosciences (DTIL)
DTIL traded between 5.97 and 11.24 across 12 sessions. The latest close on file is 9.53.
A simple score for Precision Biosciences (DTIL)
14 out of 100
“8-K - PRECISION BIOSCIENCES INC (0001357874) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.